Mortality and prehospital thrombolysis for acute myocardial infarction. A meta-analysis

JAMA

Volumn 283, Issue 20, 2000, Pages 2686-2692

  Morrison, Laurie J ^a,c   Verbeek, P Richard ^a   McDonald, Andrew C ^a   Sawadsky, Bruce V ^a   Cook, Deborah J ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; REVIEW;

EID: 0034738057     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.20.2686     Document Type: Review

References (50)

1. The GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993; 329:673-682.
2. Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients [published correction appears in Lancet. 1994;343:742]. Lancet 1994;343:311-322.
3. Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients [published correction appears in Lancet. 1994;343:742]. Lancet 1994;343:311-322.
4. Selker HP, Zalenski RJ, Antman EM, et al. An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a National Heart Attack Alert Program Working Group [published correction appears in Ann Emerg Med. 1997; 29:310]. Ann Emerg Med. 1997;29:13-87.
5. Selker HP, Zalenski RJ, Antman EM, et al. An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a National Heart Attack Alert Program Working Group [published correction appears in Ann Emerg Med. 1997; 29:310]. Ann Emerg Med. 1997;29:13-87.
6. Fathordoubad F, Almohammad A, Heuhns TT, Beatt KJ. Metaanalysis of randomized trials of prehospital versus hospital thrombolysis. Heart. 1996;75 (suppl 1):169.
7. Grunewald M, Seifried E. Metaanalysis of all available published clinical trials (1958-1990) on thrombolytic therapy for AMI-relative efficacy of different therapeutic strategies. Fibrinolysis. 1994;8:67-86.
8. Le Feuvre C, Yusuf S, FlatherM, Farkouh M. Maximizing benefits of therapies in acute myocardial infarction. Am J Cardiol. 1993;72:145G-155G.
9. Anderson J. Thrombolysis for acute myocardial infarction: making sense of the clinical trials data. J Intervent Cardiol. 1992;2:127-136.
10. Weaver WD, Prehospital thrombolysis in myocardial infarction Hosp Pract (Off Ed). 1994;29:77-85.
11. Ornato JP. The earliest thrombolytic treatment of acute myocardial infarction: ambulance or emergency department? Clin Cardiol. 1990;13(8 suppl 8): VIII27-VIII31.
12. National Heart Attack Alert Program Coordinating Committee Access to Care Subcommittee. Staffing and equipping emergency medical services systems: rapid identification and treatment of acute myocardial infarction. Am J Emerg Med. 1995;13:58-66.
13. Selig MB. Early management of acute myocardial infarction: thrombolysis, angioplasty, and adjunctive therapies. Am J Emerg Med. 1996;14:209-217.
14. Woo K, White H. Thrombolytic therapy in acute myocardial infarction. Curr Opin Cardiol. 1994;9:471-482.
15. Benson NH, Maningas PA, Krohmer JR, Balcombe DJ, Swor R. Guidelines for the prehospital use of thrombolytic agents. Ann Emerg Med. 1994;23: 1047-1048.
16. Grover A, Rihal CS. The importance of early patency after myocardial infarction. Curr Opin Cardiol. 1995;10:361-366.
17. Gersh BJ, Anderson JL. Thrombolysis and myocardial salvage: results of clinical trials and the animal paradigm - paradoxic or predictable? Circulation. 1993;88:296-306.
18. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Acute myocardial infarction: pre-hospital and inhospital management. Eur Heart J. 1996;17:43-63.
19. Nee PA. Thrombolysis after acute myocardial infarction. J Accid Emerg Med. 1997;14:2-9.
20. Kowalenko T, Kereiakes DJ, Gibler WB. Prehospital diagnosis and treatment of acute myocardial infarction: a critical review. Am Heart J. 1992;123:181-190.
21. Kennedy JW. Thrombolytic therapy for acute myocardial infarction: a brief review. Heart Lung. 1987; 16(6 pt 2):740-745.
22. Carlsson J, Schuster HP, Tebbe U. Prehospital thrombolytic therapy in acute myocardial infarction [in German]. Anaesthetist. 1997;46:829-839.
23. Myers RB. Prehospital management of acute myocardial infarction: electrocardiogram acquisition and interpretation, and thrombolysis by prehospital care providers. Can J Cardiol. 1998;14:1231-1240.
24. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 1996; 348:771-775.
25. Hunt DL, McKibbon KA. Locating and appraising systematic reviews. Ann Intern Med. 1997;126: 532-538.
26. Mulrow CD, Oxman AD. Cochrane collaboration handbook [Cochrane review on CD-ROM]. Oxford, England: Cochrane Library, Update Software; 1997.
27. Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbe KA. Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol. 1992;45:255-265.
28. Breslow N, Day NE. Statistical Methods in Cancer Research. Vol 1. Lyon, France: Internatinoal Agency for Research on Cancer; 1980:142.
29. Castaigne AD, Duval AM, Dubois-Rande JL, Herve C, Jan F, Louvard Y. Prehospital administration of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Drugs. 1987;33 (suppl 3):231-234.
30. Barbash Gl, Roth A, Hod H, et al. Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarction. Am J Cardiol. 1990;66:261-266.
31. Boissel JP. The European Myocardial Infarction Project: an assessment of pre-hospital thrombolysis. Int J Cardiol. 1995;49 (suppl):S29-S37.
32. Gotsman M, Gilon D, Lotan C, et al. Very early thrombolysis in acute myocardial infarction: the Jerusalem experience. Kardiologia Polska. 1996;44:6-16.
33. McAleer B, Ruane B, Burke E, et al. Prehospital thrombolysis in a rural community; short- and long-term survival. Cardiovasc Drugs Ther. 1992;6:369-372.
34. McNeill AJ, Cunningham SR, Flannery DJ, et al. A double blind placebo controlled study of early and late administration of recombinant tissue plasminogen activator in acute myocardial infarction. Br Heart J. 1989;61:316-321.
35. Risenfors M, Gustavsson G, Ekstrom L, et al. Prehospital thrombolysis in suspected acute myocardial infarction: results from the TEAHAT Study. J Intern Med Suppl. 1991;229:3-10.
36. Rozenman Y, Gotsman MS, Weiss AT, et al. Early intravenous thrombolysis in acute myocardial infarction: the Jerusalem experience. Int J Cardiol. 1995; 49(suppl):S21-S28.
37. Castaigne AD, Herve C, Duval-Moulin AM, et al. Prehospital use of APSAC: results of a placebo-controlled study. Am J Cardiol. 1989;64:30A-33A.
38. The European Myocardial Infarction Project Group. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med. 1993;329:383-389.
39. GREAT group. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian Region Early Anistreplase Trial. BMJ. 1992;305: 548-553.
40. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy: The Myocardial Infarction Triage and Intervention Trial. JAMA. 1993;270:1211-1216.
41. Roth A, Barbash Gl, Hod H, et al. Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? a pilot study. J Am Coll Cardiol. 1990;15: 932-936.
42. Schofer J, Buttner J, Geng G, et al. Prehospital thrombolysis in acute myocardial infarction. Am J Cardiol. 1990;66:1429-1433.
43. Rawles J. Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol. 1994; 23:1-5.
44. Rawles J. Myocardial salvage with early anistreplase treatment. Clin Cardiology. 1997;20:6-10.
45. Brouwer MA, Martin JS, Maynard C, et al, for the MITI Project Investigators. Influence of early prehospital thrombolysis on mortality and event-free survival (the Myocardial Infarction Triage and Intervention [MITI] Randomized Trial). Am J Cardiol. 1996; 78:497-502.
46. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet. 1992;339:753-770.
47. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet. 1990;336:65-71.
48. Boersma H, van der Vlugt MJ, Arnold AE, Deckers JW, Simoons ML. Estimated gain in life expectancy: a simple tool to select optimal reperfusion treatment in individual patients with evolving myocardial infarction. Eur Heart J. 1996;17:64-75.
49. Ryan TJ, Anderson JL, Antman EM, et al. ACC/ AHA guidelines for the management of patients with acute myocardial infarction. J Am Coll Cardiol. 1996; 28:1328-1428.
50. Canto JG, Rogers WJ, Bowlby LJ, French WJ, Pearce DJ, Weaver WD, for the National Registry of Myocardial Infarction 2 Investigators. The prehospital electrocardiogram in acute myocardial infarction: is its full potential being realized? J Am Coll Cardiol. 1997;29:498-505.